ESR1 and breast cancer: The prognosis of BC with both hormone receptors (estrogen receptor [36] or progesterone receptor [PR]) positive (ER + /PR+) is better than that with only one hormone receptor positive or both hormone receptors negative, as the tumor phenotypes in the latter cases are more aggressive and have a more unfavorable prognosis [37].